中天順聯(00994.HK)擬與華際科工合作拓展電商業務
中天順聯(00994.HK)表示,與華際科工訂立諒解備忘錄,擬借助華際科工的技術產權,包括華際科工已通過初審或正在申報的專利、軟件著作權及軟硬體系統等,配合中宏順聯及黑貓天華於電子商務業務的技術優勢,共同拓展與集團電商業務相關的業務模式。
中天順聯預期,合作範圍可涵蓋基於漁交網漁獲交易平台的水產養殖捕撈業務及供應鏈相關業務,基於海陸通系統定制化的智慧船舶、港口智慧化及衛星應急調度等業務。
為聚合雙方資源,公司計劃通過可變動權益實體安排實際控制華際科工部分權益,或與華際科工成立合營公司,亦可能就華際科工的技術產權訂立專項合作安排。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.